Omninet Capital

Pattern Bioscience, Inc., known as Klaris Diagnostics, Inc., is a clinical diagnostics company based in Austin, Texas, that focuses on addressing antibiotic resistance. Founded in 2016, the company has developed a next-generation clinical microbiology platform utilizing its patented phenotypic single-cell technology. This innovative approach allows for rapid pathogen identification and antibiotic susceptibility testing without the lengthy culture processes typical of traditional methods. Pattern Bioscience's Digital Culture technology employs artificial intelligence and single-cell analysis, producing comprehensive and reliable diagnostic results significantly faster than the current standard of care. By integrating functional endpoints that account for various resistance mechanisms, the company aims to enhance the accuracy and efficiency of diagnoses in the fight against antibiotic-resistant infections.

Beyond Verbal Communication specializes in voice-driven emotion analytics technology that utilizes artificial intelligence to extract human emotions and identify vocal biomarkers, which are acoustic features that indicate various health conditions. The company collaborates with leading medical institutions to conduct clinical trials and large-scale projects aimed at detecting signs of cardiovascular, pulmonary, neurological, and other chronic diseases through vocal analysis. This innovative approach allows for continuous patient monitoring and the application of predictive analytics in healthcare. By decoding and measuring human moods, attitudes, and decision-making profiles in real-time from raw vocal intonations, Beyond Verbal enables users to gain insights into emotional characteristics and overall health, enhancing personalized healthcare screening and remote health monitoring.

RADLogics Inc. is a healthcare technology company specializing in radiology image analytics software aimed at enhancing the efficiency and accuracy of medical imaging. Founded in 2010 and based in Piedmont, California, the company has developed AlphaPoint, an advanced platform that utilizes machine learning algorithms to analyze CT, MRI, ultrasound, and X-ray scans. By aggregating and analyzing data from thousands of clinical cases, AlphaPoint can search, measure, characterize, and generate preliminary findings reports, thereby streamlining the radiology workflow. The platform is designed to improve patient outcomes while also enhancing the performance and quality of life for radiologists through automation of detection and reporting functions.

Edeniq Inc. is a biotechnology company focused on developing processes for converting cellulosic biomass into industrial sugars and cellulosic ethanol. Founded in 2006 and based in Visalia, California, Edeniq offers innovative technologies such as the Cellunator, a mixing and milling device that enhances starch extraction from corn, and the Pathway platform, which enables the production of cellulosic ethanol from existing corn ethanol plants. The company's proprietary Intellulose technology allows for seamless integration into current ethanol production facilities without requiring significant capital investment. Edeniq licenses its technologies to bio-refineries in the United States and Brazil, helping them to increase throughput, improve yields, and produce valuable biofuels and biochemicals.

The company develops code division multiple access chipsets for wireless voice and data products.

Sonics is a leading innovator in network-on-chip (NoC) technology, providing a comprehensive portfolio of intelligent on-chip communication solutions tailored for home entertainment, wireless, networking, and mobile devices. Established in 1996 and headquartered in Milpitas, California, the company specializes in streamlining complex, high-speed system-on-chip (SoC) designs by addressing memory bottlenecks and enhancing data flow within embedded systems featuring multiple cores. Sonics' silicon-proven intellectual property enables designers to create heterogeneous, multi-core SoC designs that incorporate essential subsystems for security, power, and memory, ultimately delivering high performance and energy efficiency. With its solutions, Sonics has facilitated the shipment of over 750 million units globally, solidifying its position as a vital contributor to the embedded market.

The company develops code division multiple access chipsets for wireless voice and data products.